Phase I study of camrelizumab in patients with advanced solid tumors.

ABSTRACT:

SUBMITTER: Ma Y 

PROVIDER: S-EPMC9892498 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature